This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALFRED L. WEINER, M.D.; JAN SCHWARZ, M.D.

AMA Arch Derm. 1957;76(6):783-787.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The in vitro fungistatic activity of certain antihistamine drugs has been previously recorded. Apparently there is considerable variation among different members of this group of agents in this regard. Some are altogether incapable of inhibiting fungi, whereas others possess this characteristic in varying degree. Carson and Campbell¹ demonstrated the in vitro fungistatic activity against several species of pathogenic fungi (Trichophyton mentagrophytes, Trichophyton rubrum, Trichophyton ferrugineum, Microsporum gypseum, Microsporum canis and Epidermophyton floccosum) of diphenylpyraline, antazoline (Antistine), and tripelennamine (Pyribenzamine). Concentrations as low as 0.1 mg/ml. were capable of restricting the growth of some of the organisms, but higher levels of more than 1 mg/ml. were required for complete suppression of certain fungi. Carson and Campbell found that the fungistatic effect of the drugs tested could be reduced or abolished in media adjusted to pH 5 and that for tripelennamine there was an . . . [Full Text PDF of this Article]

Author Affiliations
Cincinnati

From the Dermatological Clinics of the Cincinnati Health Department and the Laboratory of Mycology of the Department of Dermatology, University of Cincinnati College of Medicine.

Footnotes
Received for publication July 2, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?